Kardonat

Kardonat – the complex drug contributing to normalization of carbohydrate, fatty and protein metabolism.

Form of release and structure

Kardonat release in the form of capsules (in plastic containers on 30 or 60 pieces; in blister strip packagings on 10 pieces, on 3 or 6 packagings in a cardboard pack).

Active agents are a part of 1 capsule:

• Lysine a hydrochloride – 50 mg;
• Carnitine chloride – 100 mg;
• Piridoksal-5-fosfata (_B6 coenzyme) – 50 mg;
• Cocarboxylase chloride (_B1 coenzyme) – 50 mg;
• Cobamamidum (дибенкосид, _B12 coenzyme) – 1 mg.

Auxiliary components: aerosil, talc.

Indications to use

Kardonat appoint for normalization of carbohydrate, fatty and protein metabolism.

Also drug is used at the following diseases / states:

• Lag in physical and intellectual development in children (lack of appetite, disturbance of food, an adynamy, a growth inhibition);
• Lack of appetite at adults because of a physical and nerve strain;
• Physical and intellectual overstrain, including at athletes, decrease in working capacity;
• Coronary heart disease (myocardial infarction, stenocardia; along with other drugs);
• Disturbances of food of a cardiac muscle with a heavy heart;
• Chronic heart failure (along with other drugs);
• Bronchial asthma and chronic bronchitis (along with other drugs);
• Alcoholism;
• Easy forms of excess function of a thyroid gland;
• Chronic and acute disorders of cerebral circulation;
• Liver and renal failure (along with other drugs);
• Liver diseases (hepatitises, cirrhoses);
• Inflammation of peripheral nerves with painful symptoms, radiculitis;
• Iron deficiency and _{V12defitsitnaya} anemias (along with other drugs);
• Toxicosis of pregnant women;
• The states demanding improvement of fatty and carbohydrate metabolism;
• States after the postponed infectious and noninfectious diseases (during the postoperative period).

Contraindications

• Malignant tumors;
• Age till 1 year;
• Hypersensitivity to drug components.

Route of administration and dosage

Kardonat accept inside, washing down with water, fruit juice or tea. Capsules can be accepted to or after food.

Single dose – 1 capsule. Frequency rate of reception is defined by age:

• Adults and children of 15 years: 2-3 times a day;
• Children of 5-15 years: 2 times a day;
• Children of 1-5 years: once a day.

Before reception children of 1-5 years should dissolve contents of the capsule previously in 50-100 ml of sweet water or any fruit juice. Such route of administration is also allowed at patients during the postoperative period and at the patients who had a stroke, a myocardial infarction.

The average duration of therapy – 3-4 weeks.

Side effects

As a rule, Kardonat is had well, but in rare instances (usually at individual intolerance) excitement, a cardiopalmus, decrease or increase in arterial pressure, a skin itch, frustration of a chair, abdominal distention can develop.

In case of development of the described disturbances it is necessary to consult with the doctor concerning expediency of further therapy.

Special instructions

Before Kardonat's use, and also in the absence of improvement or at an aggravation of symptoms it is necessary to consult at the doctor.

Without medical consultation it is not necessary to accept Kardonat longer than the recommended term.

Patients with a diabetes mellitus it is necessary to control glucose level in blood as the carnitine improves its assimilation.

Medicinal interaction

Kardonat can strengthen effect of cardiac glycosides, antihypertensives, insulin and other antihyperglycemic medicines, and also expanding peripheral blood vessels of drugs.

It is not recommended to accept drug to the patients with Parkinson's disease accepting a levodopa.

Kardonat does not interact with foodstuff and alcohol.

Terms and storage conditions

To store in the place, unavailable to children, at a temperature of 15-25 °C.

Period of validity – 2 years.